Cargando…
Anti-cancer potency of tasquinimod is enhanced via albumin-binding facilitating increased uptake in the tumor microenvironment
Tasquinimod, an orally active quinoline-3-carboxamide, binds with high affinity to HDAC4 and S100A9 in cancer and infiltrating host cells within compromised tumor microenvironment inhibiting adaptive survival pathways needed for an angiogenic response. Clinical trials document that as low as 0.5-1mg...
Autores principales: | Isaacs, John T., Dalrymple, Susan L., Rosen, D. Marc, Hammers, Hans, Olsson, Anders, Leanderson, Tomas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4226669/ https://www.ncbi.nlm.nih.gov/pubmed/25193858 |
Ejemplares similares
-
Tasquinimod (ABR-215050), a quinoline-3-carboxamide anti-angiogenic agent, modulates the expression of thrombospondin-1 in human prostate tumors
por: Olsson, Anders, et al.
Publicado: (2010) -
Tasquinimod triggers an early change in the polarization of tumor associated macrophages in the tumor microenvironment
por: Olsson, Anders, et al.
Publicado: (2015) -
Mechanisms of action of tasquinimod on the tumour microenvironment
por: Raymond, E., et al.
Publicado: (2013) -
The anti-tumor effect of the quinoline-3-carboxamide tasquinimod: blockade of recruitment of CD11b(+) Ly6C(hi) cells to tumor tissue reduces tumor growth
por: Deronic, Adnan, et al.
Publicado: (2016) -
Erratum to: The anti-tumor effect of the quinoline-3-carboxamide tasquinimod: blockade of recruitment of CD11b(+) Ly6C(hi) cells to tumor tissue reduces tumor growth
por: Deronic, Adnan, et al.
Publicado: (2016)